Skip to content
  • beauty
  • cleaning
  • pharma

Medium-chain triglycerides

CAS 438544-49-1 · 0/100 · High conf.

Concern score

0/100Low concern — well-established and permitted without restriction (CIR safe as used; EU CosIng).
High confidence

Medium-chain triglycerides in plain language

What it is

Also known as Medium-​chain glycerides · Actor M 4 · Bergabest MCT · Coconad · medium-chain Glycerides · Medium chain triglycerides (MCTs)

Show all 7 names

Medium-chain triglyceride

What it does

We don't have a plain-language description for Medium-chain triglycerides yet.

Is it a concern?
Low concern: no hazard classifications on record.

Why it's flagged

EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.

The score describes this ingredient's chemical identity — its hazard profile from published classifications and regulatory status — not the safety of any product it appears in.

Regulation

No restrictions found. Medium-chain triglycerides appears in these published regulatory listings.

  • In marketed US drugs
  • Inactive ingredient in US drugs

Recorded in these product areas

  • Found in consumer products
  • Beauty
  • Cleaning
  • USFDAinactive ingredient database19 entries — 6 administration routes
    • Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 1.1 %w/vSource →
    • Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 4771 mgSource →
    • Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 866 mgSource →
    • Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 3390 mg/5mlSource →
    • Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 5566 mgSource →
    • Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 10170 mgSource →
    • Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2 mgSource →
    • Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 0.37 mgSource →
    • Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mgSource →
    • Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 990 mgSource →
    • Route: SUBLINGUAL; Dosage form: POWDER; Maximum daily exposure: 2 mgSource →
    • Route: SUBLINGUAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 110 mgSource →
    • Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 10.87 %w/wSource →
    • Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 570 mgSource →
    • Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 12 mgSource →
    • Route: TOPICAL; Dosage form: LOTION; Potency: 7 %w/wSource →
    • Route: TOPICAL; Dosage form: OINTMENT; Potency: 20 %w/wSource →
    • Route: TOPICAL; Dosage form: SPRAY; Maximum daily exposure: 540 mgSource →
    • Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NASource →
  • USEPAcommercial use observedEPA CPDat observed this chemical in 12 composition records across product categories including Personal care.
    • EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.Source →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 1 active drug products and 4 total products.
    • FDA NDC lists this ingredient in 1 active drug products and 4 total products.Source →

Expert safety opinions

No expert opinion on file for Medium-chain triglycerides. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.

  • SCCS

    EU Scientific Committee on Consumer Safety

    No SCCS opinion on file.

  • CIR

    Cosmetic Ingredient Review (US expert panel)

    No CIR safety assessment on file.

Evidence & sources

No graded research studies for Medium-chain triglycerides yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

4 data sources

Where this comes from

  • EPA Chemical and Products Database

    exposure · updated July 2015

    Open →
  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →
  • FDA Inactive Ingredient Database

    regulatory · updated 2026-01-09

    Open →
  • FDA National Drug Code Directory

    regulatory · updated 2028-01-16

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

No fragrance-linked caution surfaced in the current profile.

Good fit

This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.

Where it has been recorded

How often EPA CPDat has listed Medium-chain triglycerides in a product composition. These are source records, not Greenveil catalog products.

Source records

12

Named organisations

6

Personal care
See products using Medium-chain triglycerides →

Catalog

Found in these products

Their ingredient lists include Medium-chain triglycerides; each product's own rating depends on its whole formula, so it is shown on the product page, not here.

Co-occurrence

Often appears with

Ingredients that frequently appear alongside Medium-chain triglycerides in the catalog.